X0306 4 2018-08-27 0 0001657197 Cotiviti Holdings, Inc. COTV 0001360891 Musallam Ramzi M C/O VERITAS CAPITAL FUND MANAGEMENT, LLC 9 WEST 57TH STREET, 29TH FLOOR NEW YORK NY 10019 0 0 1 0 0001603522 Verisk Health, Inc. / DE C/O VERSCEND TECHNOLOGIES, INC. 201 JONES ROAD, 4TH FLOOR WALTHAM MA 02451 0 0 0 1 See Remarks 0001745089 Verscend Holding Corp. C/O VERSCEND TECHNOLOGIES, INC. 201 JONES ROAD, 4TH FLOOR WALTHAM MA 02451 0 0 0 1 See Remarks 0001745090 Verscend Holding II Corp. C/O VERSCEND TECHNOLOGIES, INC. 201 JONES ROAD, 4TH FLOOR WALTHAM MA 02451 0 0 0 1 See Remarks 0001745091 Verscend Intermediate Holding Corp. C/O VERSCEND TECHNOLOGIES, INC. 201 JONES ROAD, 4TH FLOOR WALTHAM MA 02451 0 0 0 1 See Remarks 0001745092 Verscend Holdings L.L.C. C/O VERITAS CAPITAL FUND MANAGEMENT, LLC 9 WEST 57TH STREET, 29TH FLOOR NEW YORK NY 10019 0 0 0 1 See Remarks 0001614239 Veritas Capital Fund V, L.P. C/O VERITAS CAPITAL FUND MANAGEMENT, LLC 9 WEST 57TH STREET, 29TH FLOOR NEW YORK NY 10019 0 0 0 1 See Remarks 0001745093 Veritas Capital Partners V, L.L.C. C/O VERITAS CAPITAL FUND MANAGEMENT, LLC 9 WEST 57TH STREET, 29TH FLOOR NEW YORK NY 10019 0 0 0 1 See Remarks Common Stock 2018-08-27 4 J 0 94027266 44.75 A 100 I See footnote On August 27, 2018, pursuant to the Agreement and Plan of Merger, dated as of June 19, 2018, by and among the Issuer, Verscend Technologies, Inc., a Delaware corporation ("Verscend"), and Rey Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Verscend ("Merger Sub"), Merger Sub merged (the "Merger") with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Verscend. As a result of the effectiveness of the Merger, the common stock, par value $0.001 per share of Cotiviti (the "Shares"), ceased to be traded on the New York Stock Exchange, the registration of the Shares will be terminated pursuant to Section 12(g) of the Exchange Act and Cotiviti will no longer be required to file periodic reports with the SEC. Each of the Reporting Persons disclaims any beneficial ownership of these Securities, except to the extent of its pecuniary interests therein. /s/ Ramzi M. Musallam 2018-08-29 /s/ Emad Rizk, Chief Executive Officer and President of Verscend Technologies, Inc. 2018-08-29 /s/ Emad Rizk, Chief Executive Officer and President of Verscend Holding Corp. 2018-08-29 /s/ Emad Rizk, Chief Executive Officer and President of Verscend Holding II Corp. 2018-08-29 /s/ Emad Rizk, Chief Executive Officer and President of Verscend Intermediate Holding Corp. 2018-08-29 /s/ Ramzi M. Musallam, Chief Executive Officer and Managing Partner of Veritas Capital Fund Management, L.L.C., the non-member manager of Verscend Holdings LLC 2018-08-29 /s/ Ramzi M. Musallam, Managing Partner of Veritas Capital Partners V, L.L.C., the general partner of The Veritas Capital Fund V, L.P. 2018-08-29 /s/ Ramzi M. Musallam, Managing Partner of Veritas Capital Partners V, L.L.C. 2018-08-29